Exposure to environmental endocrine disruptors (EEDs) contributes to the pathogenesis of
many metabolic disorders. Here, we have analyzed the effect of the EED-nonylphenol (NP) …

Endocrine-disrupting chemical (EDC) has been thought to play a role in non-alcoholic fatty
liver disease (NAFLD). However, the toxic effects of Nonylphenol (NP), an EDC, on non …

More and more evidence indicates that persistent organic pollutants (POPs) are a risk factor
for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) …

Non-alcoholic fatty liver disease (NAFLD) has increasingly become a serious public health
problem. There is growing evidence that nonylphenol (NP) exposure may cause steatosis …

Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease. The literature suggests
that the aryl hydrocarbon receptor (AHR) may be a key player in the pathogenesis of …

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disorder. With the
improvement in human living standards, the prevalence of NAFLD has been increasing in …

An emerging literature suggests that early life exposure to 4-nonylphenol (4-NP), a
widespread endocrine disrupting chemical, may increase the risk of metabolic syndrome. In …

Nonalcoholic fatty liver disease (NAFLD) is caused by fat accumulation and is related with
obesity and oxidative stress. In this study, we investigated the effect of cuminaldehyde on …

Abstract Niemann-pick C1-like 1 (NPC1L1) mediates cholesterol absorption and plays a key
role in the pathogenesis of nonalcoholic simple fatty liver (NASFL). Our previous study …

Abstract Di (2-ethylhexyl) phthalate (DEHP) may be responsible for inducing alterations
similar to those encountered in nonalcoholic fatty liver disease (NAFLD). The aim of the …